Age Related Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Age Related Macular Degeneration Pipeline Drugs Market Report Overview
Age related macular degeneration is the most common reason for vision loss in people aged above 50. It results in the depreciation of the macula which may lead to distorted or blurry central vision. The predisposing factors involved are age, smoking, sunlight, heredity, etc. Symptoms include the development of blind spots and hazy vision. The condition may be treated by photodynamic therapy, radiation therapy, and medication such as anti-angiogenic drugs.
The Age Related Macular Degeneration pipeline drugs market research report provides comprehensive information on the therapeutics under development for Age Related Macular Degeneration, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report offers an overview of key players involved in therapeutic development for Age Related Macular Degeneration and features dormant and discontinued projects.
Age Related Macular Degeneration Pipeline Drugs Market Segmentation by Targets
The key targets in the Age Related Macular Degeneration pipeline drugs market are Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factor, Angiopoietin 2, Angiopoietin 1 Receptor, and Others. Vascular Endothelial Growth Factor A has the highest number of products in development in the Age Related Macular Degeneration pipeline drugs market.
Age Related Macular Degeneration Pipeline Drugs Market Analysis by Targets
For more target insights into the Age Related Macular Degeneration pipeline drugs market, download a free report sample
Age Related Macular Degeneration Pipeline Drugs Market Segmentation by Mechanisms of Action
The key mechanisms of action in the Age Related Macular Degeneration pipeline drugs market are Vascular Endothelial Growth Factor A Inhibitor, Vascular Endothelial Growth Factor Inhibitor, Angiopoietin 2 Inhibitor, Placenta Growth Factor Inhibitor, Angiopoietin 1 Receptor Agonist, and Others. Vascular Endothelial Growth Factor A Inhibitor leads the Age Related Macular Degeneration pipeline drugs market in terms of MoA.
Age Related Macular Degeneration Pipeline Drugs Market Analysis by Mechanisms of Action
For more MoA insights into the Age Related Macular Degeneration pipeline drugs market, download a free report sample
Age Related Macular Degeneration Pipeline Drugs Market Segmentation by Routes of Administration
The key routes of administration in the Age Related Macular Degeneration pipeline drugs market intravitreal, oral, ophthalmic, intraocular, and others. The intravitreal RoA has the highest number of Age Related Macular Degeneration drugs in development in 2022.
Age Related Macular Degeneration Pipeline Drugs Market Analysis by Routes of Administration
For more MoA insights into the Age Related Macular Degeneration pipeline drugs market, download a free report sample
Age Related Macular Degeneration Pipeline Drugs Market Segmentation by Molecule Types
The key molecule types in the Age Related Macular Degeneration pipeline drugs market are small molecule, monoclonal antibody, gene therapy, biologic, and others. Small molecule leads the Age Related Macular Degeneration pipeline drugs market in terms of molecule type in 2022.
Age Related Macular Degeneration Pipeline Drugs Market Analysis by Molecule Types
For more molecule type insights into the Age Related Macular Degeneration drugs market, download a free report sample
Age Related Macular Degeneration Pipeline Drugs Market - Competitive Landscape
Some of the leading companies in the Age Related Macular Degeneration pipeline drugs market are Nextgen Bioscience, Shanghai Novamab Biopharmaceuticals Co Ltd, YD Life Science Co, AmMax Bio Inc, and others. Nextgen Bioscience is one of the companies with the highest number of Age Related Macular Degeneration drugs in development in 2022.
Age Related Macular Degeneration Pipeline Drugs Market Analysis by Companies
To know more about the leading Age Related Macular Degeneration pipeline drugs market players, download a free report sample
Age Related Macular Degeneration Pipeline Products Market Overview
| Key Targets | Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factor, Angiopoietin 2, Angiopoietin 1 Receptor, and Others |
| Key Mechanisms of Action | Vascular Endothelial Growth Factor A Inhibitor, Vascular Endothelial Growth Factor Inhibitor, Angiopoietin 2 Inhibitor, Placenta Growth Factor Inhibitor, Angiopoietin 1 Receptor Agonist, and Others |
| Key Routes of Administration | Intravitreal, Oral, Ophthalmic, Intraocular, and Others |
| Key Molecule Type | Small Molecule, Monoclonal Antibody, Gene Therapy, Biologic, and Others |
| Leading Companies | Nextgen Bioscience, Shanghai Novamab Biopharmaceuticals Co Ltd, YD Life Science Co, AmMax Bio Inc, and Others |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Age Related Macular Degeneration.
- The pipeline guide reviews pipeline therapeutics for Age Related Macular Degeneration by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Age Related Macular Degeneration therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Age Related Macular Degeneration therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Age Related Macular Degeneration
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Age Related Macular Degeneration.
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding the Age Related Macular Degeneration pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understanding from the know-how what drove them from the pipeline.
Key Players
Table of Contents
List of Tables
List of Figures
Frequently Asked Questions
The key targets in the Age Related Macular Degeneration pipeline drugs market are Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factor, Angiopoietin 2, Angiopoietin 1 Receptor, and others.
The key MoA in the Age Related Macular Degeneration pipeline drugs market are Vascular Endothelial Growth Factor A Inhibitor, Vascular Endothelial Growth Factor Inhibitor, Angiopoietin 2 Inhibitor, Placenta Growth Factor Inhibitor, Angiopoietin 1 Receptor Agonist, and others.
The key RoA in the Age Related Macular Degeneration pipeline drugs market are intravitreal, oral, ophthalmic, intraocular, and others.
The key molecule types in the Age Related Macular Degeneration pipeline drugs market are small molecule, monoclonal antibody, gene therapy, biologic, and others.
Some of the leading companies in the Age Related Macular Degeneration pipeline drugs market are Nextgen Bioscience, Shanghai Novamab Biopharmaceuticals Co Ltd, YD Life Science Co, AmMax Bio Inc, and Others.
Get in touch to find out about our multi-purchase discounts
reportstore@globaldata.com
Tel +44 (0) 20 7947 2960
Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.
Still undecided about purchasing this report?
Testimonial
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.